<DOC>
	<DOCNO>NCT00210808</DOCNO>
	<brief_summary>The purpose study evaluate safety effectiveness topiramate compare placebo reduce number binge day patient moderate severe binge-eating disorder associate obesity .</brief_summary>
	<brief_title>A Study Effectiveness Safety Topiramate Treatment Moderate Severe Binge-eating Disorder Associated With Obesity</brief_title>
	<detailed_description>Binge-Eating Disorder ( BED ) characterize recurrent binge eat without extreme behavior lose weight ( e.g. , self-induced vomiting , misuse laxative ) result marked distress , feeling loss control , association overweight obesity . Treatment goal binge-eating therapy include reduce urge binge , weight loss , management co-existing medical psychological condition . Currently , approve medication treatment available BED , however , study show treatment BED ( psychotherapy use medication ) may effective reduce number binge , effect weight variable . Topiramate approve epilepsy adult child age 2 year , prevention migraine adult . This randomized , double-blind , flexible dose , parallel group study determine topiramate , prescription medication approve Food &amp; Drug Administration treatment epilepsy prevention migraine , administer dose 400 mg per day subject 's maximum tolerate dose , safe effective compare placebo patient moderate severe binge-eating disorder associate obesity . Subjects equal chance receive topiramate placebo . The study hypothesis topiramate effective placebo reduce number binge day per week patient moderate severe binge-eating disorder associate obesity generally well tolerate . Patients complete 16-week double-blind phase trial eligible participate 12-week open-label phase study . Topiramate tablet ( 25 and/or 100 mg ) placebo increase dos start 25 mg/day 400 mg/ day ( MTD ) first 8 wks , achieve dose maintain additional 8 wks . If enter OL reduce DB medication increase dose active topiramate 400mg/day MTD addn 12 wks .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Binge-Eating Disorder</mesh_term>
	<mesh_term>Feeding Eating Disorders</mesh_term>
	<mesh_term>Bulimia</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>Diagnosis bingeeating disorder 3 binge day per week 2 week prior baseline Obese ( body mass index &gt; =30 &lt; =50 kilogram per square meter ) Uncomplicated/controlled Type II diabetes hypertension acceptable In generally good health If female capable child , use acceptable method birth control No current past history schizophrenia , psychotic disorder , bipolar disorder Significant depression require treatment medication therapy At risk self others No current recent ( within 3 month ) diagnosis abuse drug alcohol Initiation formal psychiatric therapy past 6 month bingeeating disorder psychiatric disorder Pregnant breastfeeding No clinically significant medical condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Binge-Eating Disorder</keyword>
	<keyword>medication treatment</keyword>
	<keyword>obesity</keyword>
	<keyword>bingeing</keyword>
</DOC>